Activity Overview
This online, on-demand virtual symposium brings together renowned experts in metastatic triple-negative breast cancer (mTNBC). In this educational program, these experts discuss clinical trial data supporting new frontline antibody-drug conjugates (ADC) and ADC-immunotherapy combination approaches in mTNBC. Case discussions, an overview of trial data, and panel discussions with faculty help learners evaluate clinical trial data informing new frontline treatments and integrate emerging ADC-based evidence to optimize treatment sequencing.
This educational activity is an archive of the live symposium held on July 29, 2026.
Target Audience
This educational activity is directed toward medical oncologists, advanced practice providers, nurses, pathologists, and other health care professionals involved in the management of mTNBC.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Evaluate clinical trial data informing new frontline treatments for patients with metastatic TNBC
- Integrate emerging evidence on new ADC-based approaches to optimize treatment sequencing in patients with metastatic TNBC
Tiffany A. Traina, MD, FASCO
Associate Attending Physician
Vice Chair, Oncology; Department of Medicine
Section Head, Triple Negative Breast Cancer Clinical Research Program
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine, Weill Cornell Medicine
New York, NY
Disclosures: Advisor, Consultant, Speaker, Honoraria Recipient: AstraZeneca, Aktis Oncology, BioNTech SE, Daiichi Sankyo, Ellipses Pharma, Exact Sciences, Genentech/Roche, Gilead Sciences, Merck, Pfizer, Stemline Therapeutics, Tersera; Grant/Research Funding (to institution): Astellas Pharma, AstraZeneca, BioNTech SE, Daiichi Sankyo, Genentech/Roche, Pfizer
Nour Abuhadra, MD
Assistant Professor
Co-Director, Rare Breast Cancer Program, Department of Medicine
Co–Section Head, Triple Negative Breast Cancer Clinical Research Program
Department of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY
Disclosures: Nour Abuhadra, MD, has no relevant financial relationships with ineligible companies.
Joshua Z. Drago, MD, MS
Assistant Attending Physician
Memorial Sloan Kettering Cancer Center
New York, NY
Disclosures: Consulting: AstraZeneca, Baird Conferences, Boehringer Ingelheim, MEDACorp; Research Funding: AstraZeneca, Jazz Therapeutics, Merck; Equity: Saccharo
Ya Haddy Sallah, MD, MPH
Assistant Attending
Department of Medicine
Breast Medicine Service
Memorial Sloan Kettering Cancer Center
New York, NY
Disclosures: Ya Haddy Sallah, MD, MPH, has no relevant financial relationships with ineligible companies.
The staff of Physicians’ Education Resource®, LLC have no relevant financial relationships with ineligible companies.
PER® mitigated all conflicts of interest for faculty, staff, and planners prior to the start of this activity by using a multistep process.
Off-Label Disclosure and Disclaimer
This accredited continuing education activity was planned in accordance with the ACCME Standards for Integrity and Independence to ensure balance, objectivity, independence, and scientific rigor. Faculty were instructed to use generic names when possible and to base recommendations on the best available evidence. Proprietary product names may be referenced in clinical discussion for educational purposes only and do not imply endorsement.
This activity may include discussion of investigational, unapproved, or off‑label uses of drugs or devices. Learners are advised to consult prescribing information for products discussed. Content is provided for educational purposes only and is not a substitute for the independent clinical judgment of a health care professional. Learners are encouraged to critically evaluate the information presented and apply their own clinical judgment.
The views expressed are those of the individual faculty members and do not necessarily reflect the views of the accredited provider or any entity providing commercial support.
This activity may have used AI-assisted tools to support educational development. All content was reviewed and approved by qualified faculty or planners. The accredited provider retains full responsibility for accuracy, balance, and independence.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
